Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 32

1.

A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.

Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G.

N Engl J Med. 1999 Jan 7;340(1):1-8.

2.

Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.

Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C.

Ann Intern Med. 1997 Aug 15;127(4):267-74.

PMID:
9265425
3.

Diagnosis and treatment of bacteremia and intravascular catheter infections.

Bullard KM, Dunn DL.

Am J Surg. 1996 Dec;172(6A):13S-19S. Review.

PMID:
9003685
4.

Complications associated with the use of central venous access devices.

Whitman ED.

Curr Probl Surg. 1996 Apr;33(4):309-78. Review. No abstract available.

PMID:
8601333
5.

Parenteral nutrition associated with increased infection rate in children with cancer.

Christensen ML, Hancock ML, Gattuso J, Hurwitz CA, Smith C, McCormick J, Mirro J Jr.

Cancer. 1993 Nov 1;72(9):2732-8.

7.

Gram-negative bacterial sepsis and sepsis syndrome.

Dunn DL.

Surg Clin North Am. 1994 Jun;74(3):621-35. Review.

PMID:
8197534
8.

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, et al.

JAMA. 1994 Jun 15;271(23):1836-43.

PMID:
8196140
9.
10.

Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients.

Andrivet P, Bacquer A, Ngoc CV, Ferme C, Letinier JY, Gautier H, Gallet CB, Brun-Buisson C.

Clin Infect Dis. 1994 Feb;18(2):199-206.

PMID:
8161627
11.

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.

Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, et al.

N Engl J Med. 1994 Nov 17;331(20):1325-30.

12.

Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients.

Johnson DC, Johnson FL, Goldman S.

Pediatr Infect Dis J. 1994 Oct;13(10):930-1. No abstract available.

PMID:
7854895
13.
14.
16.

Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients.

Wells CL, Juni BA, Cameron SB, Mason KR, Dunn DL, Ferrieri P, Rhame FS.

Clin Infect Dis. 1995 Jul;21(1):45-50.

PMID:
7578758
17.

Venous access: a prospective, randomized study of the Hickman catheter.

Wagman LD, Kirkemo A, Johnston MR.

Surgery. 1984 Mar;95(3):303-8.

PMID:
6701786
18.

The management of central intravenous catheter infections.

Wang EE, Prober CG, Ford-Jones L, Gold R.

Pediatr Infect Dis. 1984 Mar-Apr;3(2):110-3.

PMID:
6427760
19.
20.

Supplemental Content

Support Center